US Patent Issued to Soin Therapeutics on July 1 for "Methods of using low dose naltrexone to treat chronic pain" (California, Ohio Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,340, issued on July 1, was assigned to Soin Therapeutics LLC (Dayton, Ohio).

"Methods of using low dose naltrexone to treat chronic pain" was invented by Amol N. Soin (Dayton, Ohio), Shweta U. Sinkar (San Diego) and Robert P. Giannini Jr. (Riverside, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of using low dose naltrexone to treat chronic pain in a patient. The methods of using low dose naltrexone to treat chronic pain generally includes administering to the patient a first amount of naltrexone in an immediate-release agent and a second amount of naltrexone in a modified-release agent."

The patent was filed on June 13, 2022, under ...